Market Overview

Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

Share:
Related AGN
Jim Cramer Weighs In On Teva, International Paper And Inogen
Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing
ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC ... (GuruFocus)
Related VRX
What's The FDA Saying About Valeant's Manufacturing Facility Issues?
Valeant's CEO Details The Company's 'Great Progress' And What's Next
Toronto Dominion Bank Buys Reynolds American Inc, International Business Machines Corp, ... (GuruFocus)

Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today filed an answer
in the United States District Court for the Central District of California
responding to Valeant Pharmaceuticals International, Inc. (“Valeant”) and
Pershing Square Capital Management, L.P.'s (“Pershing Square”) counterclaims
regarding Allergan's statements on the unsustainability of Valeant's
underlying business model.

The federal court case is Allergan, Inc. v. Valeant Pharmaceuticals
International, Inc., No. 14-CV-1214-DOC (ANx) (C.D. Cal.).

Posted-In: News Hedge Funds Legal Press Releases General

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!